methyl salicylate
Approved
Feb 20, 2008
Methyl salicylate (oil of wintergreen or wintergreen oil) is an organic compound with the formula C8H8O3. It is the methyl ester of salicylic acid. It is a colorless, viscous liquid with a sweet, fruity odor reminiscent of root beer (in which it is used as a flavoring), but often associatively called "minty", as it is an ingredient in mint candies. It is produced by many species of plants, particularly wintergreens. It is also produced synthetically, used as a fragrance and as a flavoring agent. — Wikipedia
Clinical trial activity
6 trials · 8 clinical orgs · 1 marketing orgs
Earliest trial started Apr 7, 2009 (NCT03362216)
Timeline
2000s
- Feb 20, 2008
Hisamitsu Pharmaceutical Co., Inc. — Earliest FDA Approval
- Feb 20, 2008
Hisamitsu Pharmaceutical Co., Inc. — NDA Secondary Org
- Feb 20, 2008
Hisamitsu Pharmaceutical Co., Inc. — NDA Organization
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
2020s
- Jan 1, 2022
Earliest Phase 3 Sponsor(trial)
Indications
Approved for
Studied for
Mechanism of action
- Unspecified targetOTHER
Unknown
Combination products
salonpas
with menthol
Approval history
- approvedFeb 20, 2008
Chemistry & pharmacology
SMILES
COC(=O)c1ccccc1O- Mol. weight
- 152.15 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- Yes
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
- Delivery
- Topical
- Availability
- Over the Counter
Oral
No
Parenteral
No
Topical
Yes
Sources
- WikipediaMethyl salicylate ↗
- ChEMBLCHEMBL108545 ↗
Also known as
- 2-carbomethoxyphenol
- 2-carbomethoxyphenol
- 2-hydroxybenzoic acid methyl ester
- 2-hydroxybenzoic acid methyl ester
- 2-(methoxycarbonyl)phenol
- 2-(methoxycarbonyl)phenol
- analgit
- aspellin
- balmosa
- bengue's balsam
- betula oil
- betula oil
- betula oil
- birch oil, sweet
- birch oil, sweet
- deep heat
- deep heat
- dubam
- gaultheria
- gaultheria
- gaultheria oil
- gaultheria oil
- gaultheria oil
- gppe lin
- gppe rub
- hewedolor
- linsal
- luma
- luma
- menthyl salicylate
- menthyl salicylate
- menthyl salicylate, (+/-)-
- menthyl salicylate, (+/-)-
- methyl 2-hydroxybenzoate
- methyl 2-hydroxybenzoate
- methyl 2-hydroxybenzoate
- methyl ester 2-hydroxy benzoic acid
- methyl o-hydroxybenzoate
- methyl o-hydroxybenzoate
- methylsalicylate
- methylsalicylate
- methylsalicylate
- methyl salicylate
- methyl salicylate
- methyl salicylate
- methyl salicylate
- methyl salicylate
- methyl salicylate
- methyl salicylate
- methyl salicylate
- methyl salicylate
- methyl salicylate
- methyl salicylate sodium salt
- metsal liniment
- nasciodine
- natural wintergreen oil
- natural wintergreen oil
- oil of wintergreen
- oil of wintergreen
- oil of wintergreen
- p.r.
- p.r.
- radian-b
- rheumabal
- rhodiaflor
- sloans
- spicewood oil
- spicewood oil
- sweet birch oil
- sweet birch oil
- sweet birch oil
- teaberry oil
- teaberry oil
- teaberry oil
- thera-gesic
- wintergreen
- wintergreen
- wintergreen oil
- wintergreen oil
- wintergreen oil
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05411913 | Phase 3 | Jul 1, 2022 | Apothyx, Co. |
| NCT04900129 | Phase 1 | Dec 1, 2020 | Sher-E-Bangla Medical College |
| NCT02400320 | Phase 4 | Mar 1, 2016 | GlaxoSmithKline |
| NCT02874963 | N/A | Nov 1, 2015 | University Clinical Centre of Kosova, University of Ljubljana |
| NCT02666846 | Phase 1 | Mar 1, 2015 | Futura Medical Developments Ltd., Parexel |
| NCT03362216 | N/A | Apr 7, 2009 | Peking University |
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Apothyx, Co. | For profit | 1 | 1 | 1 | 2022 |
| Futura Medical Developments Ltd. | For profit | 1 | 1 | 1 | 2015 |
| GlaxoSmithKline | For profit | 1 | 1 | 1 | 2016 |
| Parexel | For profit | 1 | 0 | 1 | 2015 |
| Peking University | Academic/Hospital | 1 | 1 | 1 | 2009 |
| Sher-E-Bangla Medical College | Academic/Hospital | 1 | 1 | 1 | 2020 |
| University Clinical Centre of Kosova | Academic/Hospital | 1 | 1 | 1 | 2015 |
| University of Ljubljana | Academic/Hospital | 1 | 0 | 1 | 2015 |
Marketing (2)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| Hisamitsu Pharmaceutical Co., Inc. | For profit | NDA2 | Feb 20, 2008 |
| Hisamitsu Pharmaceutical Co., Inc. | For profit | NDA | Feb 20, 2008 |